Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Nasal Polyposis Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Nasal Polyposis Drugmarket, defines the market attractiveness level of Nasal Polyposis Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Nasal Polyposis Drug industry, describes the types of Nasal Polyposis Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Nasal Polyposis Drug market and the development prospects and opportunities of Nasal Polyposis Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Nasal Polyposis Drug market in Chapter 13.
By Player:
Cumberland Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc
Allakos Inc
OptiNose US Inc
F Hoffmann-La Roche Ltd
By Type:
AK-001
Dupilumab
Fluticasone Propionate
Ifetroban Sodium
Omalizumab
Others
By End-User:
Hospital
Clinic
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Nasal Polyposis Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Nasal Polyposis Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Nasal Polyposis Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Nasal Polyposis Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Nasal Polyposis Drug Market Analysis and Outlook to 2022
-
7.1 Global Nasal Polyposis Drug Consumption (2017-2022)
-
7.2 United States Nasal Polyposis Drug Consumption (2017-2022)
-
7.3 Europe Nasal Polyposis Drug Consumption (2017-2022)
-
7.4 China Nasal Polyposis Drug Consumption (2017-2022)
-
7.5 Japan Nasal Polyposis Drug Consumption (2017-2022)
-
7.6 India Nasal Polyposis Drug Consumption (2017-2022)
-
7.7 South Korea Nasal Polyposis Drug Consumption (2017-2022)
8 Region and Country-wise Nasal Polyposis Drug Market Analysis and Outlook to 2028
-
8.1 Global Nasal Polyposis Drug Consumption Forecast (2022-2028)
-
8.2 United States Nasal Polyposis Drug Consumption Forecast (2022-2028)
-
8.3 Europe Nasal Polyposis Drug Consumption Forecast (2022-2028)
-
8.4 China Nasal Polyposis Drug Consumption Forecast (2022-2028)
-
8.5 Japan Nasal Polyposis Drug Consumption Forecast (2022-2028)
-
8.6 India Nasal Polyposis Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Nasal Polyposis Drug Consumption Forecast (2022-2028)
9 Global Nasal Polyposis Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Nasal Polyposis Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global AK-001 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Dupilumab Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Fluticasone Propionate Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Ifetroban Sodium Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Omalizumab Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Nasal Polyposis Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Nasal Polyposis Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Nasal Polyposis Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global AK-001 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Dupilumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Fluticasone Propionate Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Ifetroban Sodium Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Omalizumab Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Nasal Polyposis Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Nasal Polyposis Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Nasal Polyposis Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Nasal Polyposis Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Nasal Polyposis Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Nasal Polyposis Drug Market Competitive Analysis
-
14.1 Cumberland Pharmaceuticals Inc
-
14.1.1 Cumberland Pharmaceuticals Inc Company Details
-
14.1.2 Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Product and Service
-
14.2 Regeneron Pharmaceuticals Inc
-
14.2.1 Regeneron Pharmaceuticals Inc Company Details
-
14.2.2 Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Product and Service
-
14.3 Allakos Inc
-
14.3.1 Allakos Inc Company Details
-
14.3.2 Allakos Inc Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Allakos Inc Nasal Polyposis Drug Product and Service
-
14.4 OptiNose US Inc
-
14.4.1 OptiNose US Inc Company Details
-
14.4.2 OptiNose US Inc Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 OptiNose US Inc Nasal Polyposis Drug Product and Service
-
14.5 F Hoffmann-La Roche Ltd
-
14.5.1 F Hoffmann-La Roche Ltd Company Details
-
14.5.2 F Hoffmann-La Roche Ltd Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 F Hoffmann-La Roche Ltd Nasal Polyposis Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Nasal Polyposis Drug
-
Figure Nasal Polyposis Drug Picture
-
Table Global Nasal Polyposis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nasal Polyposis Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Nasal Polyposis Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Nasal Polyposis Drug Consumption by Country (2017-2022)
-
Figure United States Nasal Polyposis Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Nasal Polyposis Drug Consumption and Growth Rate (2017-2022)
-
Figure China Nasal Polyposis Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Nasal Polyposis Drug Consumption and Growth Rate (2017-2022)
-
Figure India Nasal Polyposis Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Nasal Polyposis Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Nasal Polyposis Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Nasal Polyposis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Nasal Polyposis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Nasal Polyposis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Nasal Polyposis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Nasal Polyposis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Nasal Polyposis Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global AK-001 Consumption and Growth Rate (2017-2022)
-
Figure Global Dupilumab Consumption and Growth Rate (2017-2022)
-
Figure Global Fluticasone Propionate Consumption and Growth Rate (2017-2022)
-
Figure Global Ifetroban Sodium Consumption and Growth Rate (2017-2022)
-
Figure Global Omalizumab Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global AK-001 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dupilumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Fluticasone Propionate Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ifetroban Sodium Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Omalizumab Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Nasal Polyposis Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Nasal Polyposis Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Cumberland Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cumberland Pharmaceuticals Inc Nasal Polyposis Drug Product and Service
-
Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regeneron Pharmaceuticals Inc Nasal Polyposis Drug Product and Service
-
Table Allakos Inc (Foundation Year, Company Profile and etc.)
-
Table Allakos Inc Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allakos Inc Nasal Polyposis Drug Product and Service
-
Table OptiNose US Inc (Foundation Year, Company Profile and etc.)
-
Table OptiNose US Inc Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table OptiNose US Inc Nasal Polyposis Drug Product and Service
-
Table F Hoffmann-La Roche Ltd (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Ltd Nasal Polyposis Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Ltd Nasal Polyposis Drug Product and Service
-
